NR3C1, ABCB1, TNF and CYP2C19 Polymorphisms Association with the Response to the Treatment of Erythema Nodosum Leprosum

References

• Ridley DS , JoplingWH. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis.34(3), 255–273 (1966).
   PubMedGoogle Scholar
• Fava V , OrlovaM , CobatA , AlcaïsA , MiraM , SchurrE. Genetics of leprosy reactions: an overview. Mem. Inst. Oswaldo Cruz.107(Suppl.1), 132–142 (2012).
   PubMedGoogle Scholar
• Sousa ALM , FavaVM , SampaioLHet al. Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction. J. Infect. Dis.205(9), 1417–1424 (2012).
   PubMed Web of Science ®Google Scholar
• Brazilian Ministry of Health . Diretrizes para vigilância, atenção e eliminacao da hanseníase como problema de saúde pública: manual técnico-operacional hanseniase (2016). http://portalsaude.saude.gov.br/images/pdf/2016/fevereiro/04/diretrizes-eliminacao-hanseniase-4fev16-web.pdf
   Google Scholar
• Pocaterra L , JainS , ReddyRet al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am. J. Trop. Med. Hyg.74(5), 868–879 (2006).
   PubMed Web of Science ®Google Scholar
• Kahawita IP , WalkerSL , LockwoodDNJ. Leprosy type 1 reactions and erythema nodosum leprosum. An. Bras. Dermatol.83(1), 75–82 (2008).
   Web of Science ®Google Scholar
• Sarno EN , GrauGE , VieiraLM , NeryJA. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin. Exp. Immunol.84, 103–108 (1991).
   PubMed Web of Science ®Google Scholar
• Oliveira JM , RêgoJL , deLima Santana Net al. The −308 bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil. Infect. Genet. Evol.39, 147–154 (2016).
   PubMed Web of Science ®Google Scholar
• Balagon M , SaundersonPR , GelberRH. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT. Lepr. Rev.82(3), 213–221 (2011).
   PubMed Web of Science ®Google Scholar
• Negera E , WalkerSL , BoboshaKet al. The effects of prednisolone treatment on cytokine expression in patients with erythema nodosum leprosum reactions. Front. Immunol.9(189), (2018).
   PubMedGoogle Scholar
• Van Veen NHJ , LockwoodDNJ , Van BrakelWH , RamirezJ , RichardusJH. Interventions for erythema nodosum leprosum. A Cochrane review. Lepr. Rev.80(4), 355–372 (2009).
   PubMed Web of Science ®Google Scholar
• Sugumaran DS . Leprosy reactions – complications of steroid therapy. Int. J. Lepr. Other Mycobact. Dis.66(1), 10–15 (1998).
   PubMedGoogle Scholar
• Guerra J , PennaG , de CastroL , MartelliC , StefaniM. Erythema nodosum leprosum: clinical and therapeutic updateAn Bras Dermatol.77, 389–407 (2002).
   Google Scholar
• Penna GO , MartelliCMT , MarojaMDF. Thalidomide in the treatment of erythema nodosum leprosum (ENL): systematic review of clinical trials and prospects of new investigation. 80(5), 511–522 (2005).
   Google Scholar
• Sociedade Brasileira de Hansenologia , SociedadeBrasileira de Dermatologia. Projeto diretrizes hanseníase: episódios reacionais projeto diretrizes. Associação Médica Brasileira e Conselho Federal de Medicina1–19 (2003). www.saudedireta.com.br/docsupload/1331325697056.pdf
   Google Scholar
• Feuth M , BrandsmaJW , FaberWR , BhattaraiB , FeuthT , AndersonAM. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. Lepr. Rev.79(3), 254–269 (2008).
   PubMed Web of Science ®Google Scholar
• Moreira AL , SampaioEP , ZmuidzinasA , FrindtP , SmithKA , KaplanG. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med.177(6), 1675–1680 (1993).
   PubMed Web of Science ®Google Scholar
• Sampaio EP , SarnoEN , GalillyR , CohnZA , KaplanG. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med.173(3), 699–703 (1991).
   PubMed Web of Science ®Google Scholar
• Lockwood DN . The management of erythema nodosum leprosum: current and future options. Lepr. Rev.67(4), 253–259 (1996).
   PubMed Web of Science ®Google Scholar
• Wu JJ , HuangDB , PangKR , HsuS , TyringSK. Thalidomide: dermatological indications, mechanisms of action and side effects. Br. J. Dermatol.153(2), 254–273 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma D , KwatraSG. Thalidomide for the treatment of chronic refractory pruritus. J. Am. Acad. Dermatol.74(2), 363–369 (2016).
   PubMed Web of Science ®Google Scholar
• Majer-Łobodzińska A , Adamiec-MroczekJ. Glucocorticoid receptor polymorphism in obesity and glucose homeostasis. Adv. Clin. Exp. Med.26(1), 143–148 (2017).
   PubMed Web of Science ®Google Scholar
• Koper JW , Van RossumEFC , VanDen Akker ELT. Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids92, 62–73 (2014).
   PubMed Web of Science ®Google Scholar
• Ambudkar SV , Kimchi-SarfatyC , SaunaZE , GottesmanMM. P-glycoprotein: from genomics to mechanism. Oncogene22(47 REV. ISS. 6), 7468–7485 (2003).
   PubMed Web of Science ®Google Scholar
• Marino S , VerzegnassiF , TamaroPet al. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. Pediatr. Blood Cancer53(6), 984–991 (2009).
   PubMed Web of Science ®Google Scholar
• Neben K , MytilineosJ , MoehlerTMet al. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood100(6), 2263–2265 (2002).
   PubMed Web of Science ®Google Scholar
• Du J , YuanZ , ZhangCet al. Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone. Leuk. Res.34(11), 1453–1458 (2010).
   PubMed Web of Science ®Google Scholar
• Basmaci C , PehlivanM , TomatirAet al. Effects of TNFα, NOS3, MDR1 gene polymorphisms on clinical parameters, prognosis and survival of multiple myeloma cases. Asian Pac. J. Cancer Prev.17(3), 1009–1014 (2016).
   PubMedGoogle Scholar
• Ando Y , FuseE , FiggWD. Thalidomide metabolism by the CYP2C subfamily. Clin. Cancer Res.8(6), 1964–1973 (2002).
   PubMed Web of Science ®Google Scholar
• Li Y , JiangZ , XiaoY , LiL , GaoY. Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro. Hematol. Oncol.30(1), 13–21 (2012).
   PubMed Web of Science ®Google Scholar
• Costa PDSS , FragaLR , KowalskiTW , DaxbacherELR , Schuler-FacciniL , ViannaFSL. Erythema nodosum leprosum: update and challenges on the treatment of a neglected condition. Acta Trop.183, 134–141 (2018).
   PubMed Web of Science ®Google Scholar
• Sortica VA , LindenauJD , CunhaMGet al. The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment. Pharmacogenomics17(17), 1903–1911 (2016).
   PubMed Web of Science ®Google Scholar
• Liang K-Y , ZegerSL. Longitudinal data analysis using generalized linear models. Biometrika73(1), 13–22 (1986).
   Web of Science ®Google Scholar
• Wilson AG , SymonsJA , McDowellTL , McDevittHO , DuffGW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl Acad. Sci. USA94(7), 3195–3199 (1997).
   PubMed Web of Science ®Google Scholar
• Lindenau JD , AltmannV , Schumacher-SchuhAF , RiederCR , HutzMH. Tumor necrosis factor alpha polymorphisms are associated with Parkinson’s disease age at onset. Neurosci. Lett.658, 133–136 (2017).
   PubMed Web of Science ®Google Scholar
• Kamizono S , YamadaA , KimuraA , KatoH. Polymorphism of the 5’flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens51(6), 605–612 (1998).
   PubMedGoogle Scholar
• Barrett JC , FryB , MallerJ , DalyMJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2), 263–265 (2005).
   PubMed Web of Science ®Google Scholar
• Stephens M , SmithNJ , DonnellyP. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet.68(4), 978–989 (2001).
   PubMed Web of Science ®Google Scholar
• Stephens M , DonnellyP. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet.73(5), 1162–1169 (2003).
   PubMed Web of Science ®Google Scholar
• Andrade E. S. . Desequilíbrio de ligações e blocos de haplótipos determinados pelas análises de 250k SNPS em três remanescentes de Quilombos [Doctoral dissertation]. Universidade de São Paulo, São Paulo, Brazil (2013).
   Google Scholar
• Brazilian Ministry of Health . Guia prático sobre a Hanseníase1 (2017). http://portalarquivos2.saude.gov.br/images/pdf/2017/novembro/22/Guia-Pratico-de-Hanseniase-WEB.pdf
   Google Scholar
• Herrera C , MarcosM , CarbonellCet al. Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: a systematic review and meta-analysis. Autoimmun. Rev.17(5), 449–456 (2018).
   PubMed Web of Science ®Google Scholar
• Kaymak Cihan M , KarabulutHG , YürürKutlay N , IlgınRuhi H , TükünA , OlcayL. Association between N363S and BclI polymorphisms of the glucocorticoid receptor gene (NR3C1) and glucocorticoid side effects during childhood acute lymphoblastic leukemia treatment. Turkish J. Hematol.34( 2), 151–158 (2017).
   PubMed Web of Science ®Google Scholar
• Mwinyi J , WengerC , ElorantaJJ , Kullak-UblickGA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J. Gastroenterol.16(31), 3888–3896 (2010).
   PubMed Web of Science ®Google Scholar
• Manenschijn L , VanDen Akker ELT , LambertsSWJ , Van RossumEFC. Clinical features associated with glucocorticoid receptor polymorphisms: An overview. Ann. NY Acad. Sci.1179, 179–198 (2009).
   PubMed Web of Science ®Google Scholar
• Bouatou Y , StenzL , PonteB , FerrariS , Paoloni-GiacobinoA , HadayaK. Recipient rs1045642 polymorphism is associated with office blood pressure at 1-year post kidney transplantation: a single center pharmacogenetic cohort pilot study. Front. Pharmacol.9, 1–8 (2018).
   PubMed Web of Science ®Google Scholar
• Krupoves A , MacKD , SeidmanE , DeslandresC , AmreD. Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn’s disease. Inflamm. Bowel Dis.17(11), 2308–2317 (2011).
   PubMed Web of Science ®Google Scholar
• Ueda K , OkamuraN , HiraiMet al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem.267(34), 24248–24252 (1992).
   PubMed Web of Science ®Google Scholar
• Kroetz DL , Pauli-MagnusC , HodgesLMet al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics13, 481–494 (2003).
   PubMedGoogle Scholar
• Teeninga N , GuanZ , StevensJet al. Population pharmacokinetics of prednisolone in relation to clinical outcome in children with nephrotic syndrome. Ther. Drug Monit.38(4), 534–545 (2016).
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S , BurkO , von RichterOet al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA97(7), 3473–3478 (2000).
   PubMed Web of Science ®Google Scholar
• Tavares LC , MarcattoLR , SoaresRAG , KriegerJE , PereiraAC , SantosPCJL. Association between ABCB1 polymorphism and stable warfarin dose requirements in Brazilian patients. Front. Pharmacol.9, 542 (2018).
   PubMed Web of Science ®Google Scholar
• Ameyaw MM , RegateiroF , LiTet al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics11(3), 217–221 (2001).
   PubMedGoogle Scholar
• Cascorbi I , GerloffT , JohneAet al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther.69(3), 169–174 (2001).
   PubMed Web of Science ®Google Scholar
• Qidwai T , KhanF. Tumour necrosis factor gene polymorphism and disease prevalence. Scand. J. Immunol.74(6), 522–547 (2011).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Hurtado IA , Puebla-PérezAM , Delgado-SaucedoJIet al. Association between TNF-α −308G>A and −238g>a gene polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients. Genet. Mol. Res.15(2), (2016).
   PubMedGoogle Scholar
• Cardoso CC , PereiraAC , Brito-de-SouzaVNet al. TNF −308G>A single nucleotide polymorphism is associated with leprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study. J. Infect. Dis.204(8), 1256–1263 (2011).
   PubMed Web of Science ®Google Scholar
• Kroeger KM , CarvilleKS , AbrahamLJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol.34(5), 391–399 (1997).
   PubMed Web of Science ®Google Scholar
• Bouma G , CrusiusJBA , OudkerkPool Met al. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol.43(4), 456–463 (1996).
   PubMed Web of Science ®Google Scholar
• Youssef DM , El-ShalAS , HusseinS , SalahK , AhmedAERE. Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome. Cytokine.102, 76–82 (2018).
   PubMed Web of Science ®Google Scholar
• Areeshi MY , MandalRK , DarSAet al. Impact of TNF -308 G>A (rs1800629) gene polymorphism in modulation of leprosy risk: a reappraise meta-analysis of 14 case–control studies. Biosci. Rep.37(5), pii:BSR20170806 (2017).
   Google Scholar
• van Heel DA . Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kappaB transcription factors. Hum. Mol. Genet.11(11), 1281–1289 (2002).
   PubMed Web of Science ®Google Scholar
• Heidari Z , MoudiB , SaghebHM , MoudiM. Association of TNF-α gene polymorphisms with production of protein and susceptibility to chronic hepatitis B infection in the south east Iranian population. Hepat Mon.16(11), 1–11 (2016).
   Web of Science ®Google Scholar
• Hossein Ghaderian SM , NajarRA , TabatabaeiPanah AS. Tumor necrosis factor-α: investigation of gene polymorphism and regulation of TACE-TNF-α system in patients with acute myocardial infarction. Mol. Biol. Rep.38(8), 4971–4977 (2011).
   PubMed Web of Science ®Google Scholar
• Santos AR , AlmeidaAS , SuffysPNet al. Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int. J. Lepr. Other Mycobact. Dis.68(3), 325–327 (2000).
   PubMedGoogle Scholar
• Mekinian A , TamouzaR , PavySet al. Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. Eur. Cytokine Netw.22(2), 88–102 (2011).
   PubMed Web of Science ®Google Scholar
• Nabarro LEB , AggarwalD , ArmstrongM , LockwoodDNJ. The use of steroids and thalidomide in the management of erythema nodosum leprosum; 17 years at the hospital for tropical diseases, London. Lepr. Rev.87(2), 221–231 (2016).
   Web of Science ®Google Scholar
• Guerra JG , PennaGO , DeCastro LCM , MartelliCMT , StefaniMMA , CostaMB. Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services. Rev. Soc. Bras. Med. Trop.37(5), 384–390 (2004).
   PubMedGoogle Scholar
• Kumar B , DograS , KaurI. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int. J. Lepr. Other Mycobact. Dis.72(2), 125 (2004).2
   PubMedGoogle Scholar
• Voorend CGN , PostEB. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Negl. Trop. Dis.7(10), e2440 (2013).
   PubMed Web of Science ®Google Scholar
• Walker SL , BalagonM , DarlongJet al. ENLIST 1: an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum. PLoS Negl. Trop. Dis.9(9), e0004065 (2015).
   PubMed Web of Science ®Google Scholar
• Chandler DJ , HansenKS , MahatoB , DarlongJ , JohnA , LockwoodDNJ. Household costs of leprosy reactions (ENL) in rural India. PLoS Negl. Trop. Dis.9(1), e0003431 (2015).
   PubMed Web of Science ®Google Scholar
• Sales AM , de MatosHJ , NeryJAC , DuppreNC , SampaioEP , SarnoEN. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy. Brazilian J. Med. Biol. Res.40(2), 243–248 (2007).
   PubMed Web of Science ®Google Scholar